MOTS-c
WellnessAlso known as: Mitochondrial Open Reading Frame of the 12S rRNA-c, Mitochondrial-Derived Peptide MOTS-c
Emerging ResearchWhat is MOTS-c?
A mitochondrial-derived peptide encoded within the 12S rRNA gene of mitochondrial DNA. MOTS-c has gained significant attention in longevity and metabolic health communities for its exercise-mimicking effects and role in cellular energy regulation. Research is promising but still early-stage.
How it works
Activates AMPK (AMP-activated protein kinase), the same master metabolic switch triggered by exercise and calorie restriction. Regulates the folate-methionine cycle, affecting cellular metabolism and stress response. Translocates to the nucleus during metabolic stress to regulate gene expression related to glucose metabolism.
What marketers claim
- ▸exercise in a pill
- ▸reverses aging at the cellular level
- ▸cures metabolic syndrome
- ▸the most important peptide discovery in decades
What evidence supports
- ✓activates AMPK signaling pathway in cell and animal studies
- ✓improved glucose metabolism and insulin sensitivity in mouse models
- ✓exercise-induced increase in circulating MOTS-c levels documented in humans
- ✓MOTS-c levels decline with age in human plasma studies
- ✓improved physical performance in aged mice
Research evidence
Key studies on MOTS-c, summarized in plain language. This is not an exhaustive list — it highlights the most relevant findings.
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline
Finding: MOTS-c treatment improved physical capacity in young, middle-aged, and old mice. In old mice, it restored exercise capacity and improved skeletal muscle metabolism. Exercise was shown to increase endogenous MOTS-c levels in human subjects.
Limitation: Therapeutic effects demonstrated only in mice. Human data was limited to observational measurement of circulating levels after exercise.
The mitochondrial-derived peptide MOTS-c regulates metabolism via AMPK signaling
Finding: MOTS-c activated AMPK signaling, regulated the folate-methionine cycle, and improved glucose metabolism in cell models. Mice treated with MOTS-c showed resistance to diet-induced obesity.
Limitation: Foundational mechanistic study. Cell culture and mouse models. Translational relevance to humans is assumed but unproven.
Best for
What to expect
Realistic timeline based on available research. Individual results vary.
Week 1-2
No established human timeline. Animal studies show rapid AMPK activation and metabolic changes within days of administration.
Week 4-8
Anecdotal reports from early adopters mention improved exercise endurance and metabolic markers. No controlled human data to validate.
Month 3+
Potential metabolic improvements are speculative. Mouse models show improved glucose tolerance and exercise capacity over this timeframe.
Safety notes & concerns
Full safety guide →- ⚠no completed human clinical trials for therapeutic use
- ⚠most evidence comes from cell culture and mouse models
- ⚠the leap from AMPK activation to clinical anti-aging benefit is unproven
- ⚠optimal dosing, route of administration, and safety profile in humans are unknown
- ⚠available only from research peptide suppliers with no quality standards
- ⚠extremely expensive relative to other peptides
Pairs well with
Use caution with
Frequently asked questions
Can MOTS-c replace exercise?
No. While MOTS-c activates some of the same pathways as exercise (particularly AMPK), exercise produces a vast array of physiological benefits that no single peptide can replicate. MOTS-c research is interesting because it helps explain why exercise is beneficial, not because it can replace it.
Why do MOTS-c levels decline with age?
MOTS-c is encoded in mitochondrial DNA, and mitochondrial function declines with age. The reduction in circulating MOTS-c is thought to be one factor in age-related metabolic dysfunction. Whether supplementing MOTS-c can reverse this decline's effects is an active area of research.
Is MOTS-c the same as other mitochondrial peptides like Humanin?
Both are mitochondrial-derived peptides (MDPs), but they have different functions. Humanin is primarily cytoprotective and anti-apoptotic. MOTS-c is primarily metabolic, targeting the AMPK pathway. They represent a growing class of signaling molecules encoded in mitochondrial DNA.
Related wellness peptides
those interested in experimental recovery support with medical supervision
skin hydration support, joint comfort, general wellness
clinically obese patients under physician supervision, type 2 diabetes management
those following longevity research who pursue protocols with medical supervision
Take the Peptide Quiz
Get personalized recommendations
Stack Builder
Build a routine with MOTS-c
Last updated: 2025-04-09
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.